Option Care Health is a discounted, payer-neutral home infusion leader whose near-term CID disruption masks durable secular growth, strong cash generation, and meaningful valuation recovery potential.
Overview
Option Care Health is the leading independent U.S. home and alternate-site infusion provider, serving high-acuity patients through 196 locations across 43 states and reaching nearly the entire population. Its payer-neutral positioning differentiates it from CVS and UnitedHealth-owned rivals. The company has a strong long-term growth record, but Q1 2026 exposed a chronic inflammatory disease census reset that slowed revenue and forced guidance cuts. Despite this, EBITDA resilience, ambulatory infusion expansion, and secular site-of-care shifts support the long-term thesis.